Antitubercular Nanocarrier Combination Therapy: Formulation Strategies and in Vitro Efficacy for Rifampicin and SQ641-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Antitubercular Nanocarrier Combination Therapy: Formulation Strategies and in Vitro Efficacy for Rifampicin and SQ641

Published:2015-04-17 Issue:5 Volume:12 Page:1554-1563
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

D’Addio Suzanne M.¹,Reddy Venkata M.²,Liu Ying¹,Sinko Patrick J.³,Einck Leo²,Prud’homme Robert K.¹

Affiliation:

1. Department of Chemical and Biological Engineering, Princeton University, Princeton, New Jersey 08544, United States

2. Sequella Inc., Rockville, Maryland 77845, United States

3. Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey 08854, United States

Funder

National Institute of Allergy and Infectious Diseases

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/mp5008663

Reference42 articles.

1. Global Tuberculosis Report;World Health Organization:Geneva, Switzerland, 2013.

2. A Review of Efficacy Studies of 6-Month Short-Course Therapy for Tuberculosis among Patients Infected with Human Immunodeficiency Virus: Differences in Study Outcomes

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polyelectrolyte-Doped Block Copolymer-Stabilized Nanocarriers for Continuous Tunable Surface Charge;ACS Applied Nano Materials;2024-05-14

2. The Use of Particulate Systems for Tuberculosis Prophylaxis and Treatment: Opportunities and Challenges;Microorganisms;2023-08-02

3. Formulation and Scale-Up of Fast-Dissolving Lumefantrine Nanoparticles for Oral Malaria Therapy;Journal of Pharmaceutical Sciences;2023-08

4. Vitamin E as promising adjunct treatment option in the combat of infectious diseases caused by bacterial including multi-drug resistant pathogens – Results from a comprehensive literature survey;European Journal of Microbiology and Immunology;2020-12-11

5. RETRACTED: Pulmonary route of administration is instrumental in developing therapeutic interventions against respiratory diseases;Saudi Pharmaceutical Journal;2020-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3